Antifungal treatment and chronic rhinosinusitis
Tóm tắt
Chronic rhinosinusitis (CRS) is an inflammatory disease with a multifactorial etiology. Antifungal therapy is not routinely used to treat it. However, evidence implicating fungi in some forms of CRS recently has been published. Controversy exists as to whether fungi identified in sinonasal cultures are always pathogenic. Immunologic evidence supporting the role of fungi in the pathogenesis of CRS is also debated. Topical antifungal therapy is more widely used than oral therapy, with amphotericin B irrigation being the most common. Although some studies show benefit from this irrigation, others refute the efficacy. Although oral antifungal agents are used uncommonly, itraconazole is the most commonly used drug. The efficacy of oral itraconazole in CRS has never been assessed in a clinical trial. Given the current evidence, the use of antifungals to treat CRS is controversial and has limited indications.
Tài liệu tham khảo
Ponikau JU, Sherris DA, Kephart GM, et al.: Striking deposition of toxic eosinophil major basic protein in mucus: implications for chronic rhinosinusitis. J Allergy Clin Immunol 2005, 116:362–369.
Corey J, Romberger C, Shaw G: Fungal diseases of the sinuses. Otolaryngol Head Neck Surg 1990, 103:1012–1015.
Ponikau JU, Sherris DA, Kephart GM, et al.: The role of ubiquitous airborne fungi in chronic rhinosinusitis. Clin Rev Allergy Immunol 2006, 30:187–194.
Ponikau JU, Sherris DA, Kern EB, et al.: The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999, 74:877–884.
Taylor MJ, Ponikau JU, Sherris DA, et al.: Detection of fungal organisms in eosinophilic mucin using a fluoresceinlabeled chitin-specific binding protein. Otolaryngol Head Neck Surg 2002, 127:377–383.
Shin SH, Ponikau JU, Sherris DA, et al.: Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol 2004, 114:1369–1375.
Sasama J, Sherris D, Shin S, Kephart G: New paradigm for the roles of fungi and eosinophils in chronic rhinosinusitis. Otolaryngol Head Neck Surg 2005, 13:2–8.
Ferguson BJ: Categorization of eosinophilic chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2004, 12:237–242.
Pant H, Kette FE, Smith WB, et al.: Eosinophilic mucus chronic rhinosinusitis: clinical subgroups or a homogeneous pathogenic entity? Laryngoscope 2006, 116:1241–1247.
Ponikau JU, Sherris DA, Kita H, Kern EB: Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol 2002, 110:862–866.
Ricchetti A, Landis BN, Maffioli A, et al.: Effect of antifungal nasal lavage with amphotericin B on nasal polyposis. J Laryngol Otol 2002, 116:261–263.
Weschta M, Rimek D, Formanek M, et al.: Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol 2004, 113:1122–1128.
Ponikau JU, Sherris DA, Weaver A, Kita H: Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol 2005, 115:125–131.
Ebbens FA, Scadding GK, Badia L, et al.: Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol 2006, 118:1149–1156.
Weschta M, Rimek D, Formanek M, et al.: Effect of nasal antifungal therapy on nasal cell activation markers in chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 2006, 132:743–747.
Shin SH, Ye MK: Effects of topical amphotericin B on expression of cytokines in nasal polyps. Acta Otolaryngol 2004, 124:1174–1177.
Shirazi MA, Stankiewicz JA, Kammeyer P: Activity of nasal amphotericin B irrigation against fungal organisms in vitro. Am J Rhinol 2007, 21:145–148.
Liang KL, Su MC, Shiao JY, et al.: Amphotericin B irrigation for the treatment of chronic rhinosinusitis without nasal polyps: a randomized, placebo-controlled, doubleblind study. Am J Rhinol 2008, 22:52–58.
Gosepath J, Grebneva N, Mossikhin S, Mann WJ: Topical antibiotic, antifungal, and antiseptic solutions decrease ciliary activity in nasal respiratory cells. Am J Rhinol 2002, 16:25–31.
Hofer E, Neher A, Schrott-Fischer A, Nagl M: Influence of amphotericin B on the ciliary beat frequency of nasal mucosa. Laryngoscope 2004, 114:1964–1966.
Kennedy DW, Kuhn FA, Hamilos DL, et al.: Treatment of chronic rhinosinusitis with high-dose oral terbinafine: a double blind, placebo-controlled study. Laryngoscope 2005, 115:1793–1799.
Rains BM 3rd, Mineck CW: Treatment of allergic fungal sinusitis with high-dose itraconazole. Am J Rhinol 2003, 17:1–8.
Moffett AJ: Postural instillation: a new method of inducing local anesthesia in the nose. J Laryngol Otol 1941, 56:429–436.
Mygind N: Topical steroid treatment for allergic rhinitis and allied conditions. Clin Otolaryngol Allied Sci 1982, 7:343–352.